Article

Jacqueline Center, PhD: The Promise of AI to Improve Bone Health Outcomes

A conversation on new AI software which can identify a five-fold greater rate of potential fractures.

When it comes to addressing fractures and bone health, such injuries are generally treated and then forgotten about. If the patient then presents with a more serious fracture, though, it can be damaging.

Because of this, fracture liaison services have been established so that patients are actively identified and treated for fractures. The process, however, is labor-intensive.

That’s were artificial intelligence (AI) can play a role. The technology has shown efficacy and accuracy in scanning radiology reports and flagging patients with a fracture more quickly than a human expert, according to recent study findings.

Specifically, a team of Australia-based investigators developed AI software which identified a near five-fold higher number of potential fractures than the manual method. The investigators aimed to use the technology to address the treatment gap for patients with osteoporosis who fracture and are not treated.

For more information on the study and the topic of how AI can be used to identify fractures and improve bone health outcomes, HCPLive® spoke with Jacqueline Center, MBBS, FRACP, PhD, from the Garvan Institute of Medical Research in Australia. Center broke down the findings of her research presented at the Endocrine Society (ENDO) 2020 Annual Scientific Sessions, how such technologies can be implemented at your practice, and more.

Related Videos
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Rahul Aggarwal, MD | Credit: LinkedIn
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.